Invesco
BIOC

Invesco’s Biocept, Inc. BIOC Stock Holding History

Invesco’s Portfolio BIOC Stock Details BIOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-2
Closed -$4K – 3939
2018
Q2 		$4K Buy
+2
New +$4.05K ﹤0.01% 3868

Other funds holding BIOC

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
US Bancorp
US Bancorp Minneapolis, Minnesota $82.4B AUM 19.69% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Invesco's BIOC Position: Q3 2018 in Review

Invesco sold out of Biocept, Inc. (BIOC) in Q3 2018, closing a stake of 2 shares — an estimated $4K sold.

Invesco first reported a position in BIOC in Q2 2018 and held it in 1 quarter. The position peaked at $4K in Q2 2018. 8 funds tracked by Wall St. Rank hold BIOC as of Q3 2018.

  • Invesco reported no remaining Biocept, Inc. position as of Q3 2018 after selling out during the quarter.
  • Invesco sold 2 Biocept, Inc. shares in Q3 2018, an estimated $4K.
  • Invesco first reported a position in Biocept, Inc. in Q2 2018 and held it in 1 quarter.
  • Invesco's Biocept, Inc. position peaked at $4K in Q2 2018.
  • 8 funds tracked by Wall St. Rank held Biocept, Inc. as of Q3 2018.

Based on Invesco's 13F filing for Q3 2018, filed 14 Nov 2018.